Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

CONTINUUS PHARMACEUTICALS

Filed by CAPITOL COUNSEL LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-20 06:26:14 UTC.

Source-reported fields

Filing overview

Type
Registration
Posted
Jan 16, 2026
Income
Not reported
Expenses
Not reported
Filing UUID
8908ff78-6eca-4f37-a4f3-f3491b97dc62
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

ECN · Economics/Economic Development

Issues regarding incentives to reshore pharmaceutical manufacturing.

HCR · Health Issues

Issues regarding incentives to reshore pharmaceutical manufacturing.

MAN · Manufacturing

Issues regarding incentives to reshore pharmaceutical manufacturing.

MMM · Medicare/Medicaid

Issues regarding incentives to reshore pharmaceutical manufacturing.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.